Today

Agents

Chat

Arena

Discover

More

App

Xeris Biopharma CFO Steven Pieper sells 5,000 shares worth $42,500

XERS•2026-08-12

CFO share sale disclosed

Xeris Biopharma CFO Steven Pieper sold 5,000 common shares on Aug. 12, 2026 at $8.50 each.
Direct holdings fell to .

1,361,053 shares

The sale was executed under a Rule 10b5-1 trading plan adopted on Aug. 18, 2025.

Related News

Cisco forecasts annual revenue above estimates on sustained AI spending

CSCO•2026-08-12

Mayfair Gold Q2 2026 loss widens on higher Fenn-Gib exploration, NYSE listing costs, company says

MFG•2026-08-12

AEVEX To Acquire Blacksea Technologies, Strengthening Its Multi‑Domain Autonomous Systems Capabilities

Sources

S

Xeris Biopharma CFO Steven Pieper sells 5,000 shares worth $42,500

Sec

AVEX•2026-08-12

Whole Foods recalls food containing jalapenos on potential salmonella contamination

AMZN•2026-08-12

Fermi Named Lee McIntire CEO, Effective Tuesday, August 11, 2026

FRMI•2026-08-12

Xeris Biopharma CFO Steven Pieper sells 5,000 shares worth $42,500 - XERS News | Rallies